Groundbreaking lung cancer approval a big boost for AZ’s Imfinzi – pharmaphorum
pharmaphorum |
Groundbreaking lung cancer approval a big boost for AZ's Imfinzi
pharmaphorum AstraZeneca's immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients. The company announced on Friday that the FDA had approved the drug's use in patients with unresectable Stage III non … Astrazeneca shares bounce back after cancer drug approval … US clears AZ' Imfinzi for lung cancer Dr. Schwartz on the Results of the PACIFIC Trial |
